Niagen Bioscience Doubles Annual Profit, CEO Signals Acquisition Hunt And GLP-1-Style Expansion— Stock Jumps After-Hours (UPDATED)

(Editor’s note: This story and its headline have been updated to include the stock’s after-hours movement) Niagen Bioscience ...

Niagen Bioscience Inc (NAGE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...

Niagen Bioscience Inc (NAGE) reports robust financial health with significant revenue growth, despite facing increased competition and regulatory hurdles.

Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line

Q4 2025 earnings call: revenue, margins, 2026 growth guidance, Niagen Plus injection kits, telehealth plans & FDA lawsuit—read now.
Forbes

Convert Namibian Dollar To South African Rand

© 2026 Forbes Media LLC. All Rights Reserved.
Forbes

Convert United States Dollar To Namibian Dollar

© 2026 Forbes Media LLC. All Rights Reserved.
The Manila Times

Sprout Health NAD+ Injections - Compounding Status, Pharmacy Sourcing, and What Consumers Should Verify Before Any Telehealth NAD+ Enrollment in 2026

Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer ...